Author
Listed:
- Shuai Zhao
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences
University of Chinese Academy of Sciences)
- Run Tian
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Jun Wu
(Peking University Fourth School of Clinical Medicine)
- Shaoli Liu
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Yuanning Wang
(National Center for Nanoscience and Technology)
- Meng Wen
(Peking University Fourth School of Clinical Medicine)
- Yingxu Shang
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Qing Liu
(National Center for Nanoscience and Technology)
- Yan Li
(National Center for Nanoscience and Technology)
- Ying Guo
(The Second Affiliated Hospital of Xi’an Jiaotong University)
- Zhaoran Wang
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Ting Wang
(National Center for Nanoscience and Technology)
- Yujing Zhao
(Peking University Fourth School of Clinical Medicine)
- Huiru Zhao
(Peking University Fourth School of Clinical Medicine)
- Hui Cao
(Peking University Fourth School of Clinical Medicine)
- Yu Su
(Peking University Fourth School of Clinical Medicine)
- Jiashu Sun
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Qiao Jiang
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences)
- Baoquan Ding
(National Center for Nanoscience and Technology
University of Chinese Academy of Sciences
Zhengzhou University)
Abstract
Effective and safe hemodialysis is essential for patients with acute kidney injury and chronic renal failures. However, the development of effective anticoagulant agents with safe antidotes for use during hemodialysis has proven challenging. Here, we describe DNA origami-based assemblies that enable the inhibition of thrombin activity and thrombus formation. Two different thrombin-binding aptamers decorated DNA origami initiates protein recognition and inhibition, exhibiting enhanced anticoagulation in human plasma, fresh whole blood and a murine model. In a dialyzer-containing extracorporeal circuit that mimicked clinical hemodialysis, the origami-based aptamer nanoarray effectively prevented thrombosis formation. Oligonucleotides containing sequences complementary to the thrombin-binding aptamers can efficiently neutralize the anticoagulant effects. The nanoarray is safe and immunologically inert in healthy mice, eliciting no detectable changes in liver and kidney functions or serum cytokine concentration. This DNA origami-based nanoagent represents a promising anticoagulant platform for the hemodialysis treatment of renal diseases.
Suggested Citation
Shuai Zhao & Run Tian & Jun Wu & Shaoli Liu & Yuanning Wang & Meng Wen & Yingxu Shang & Qing Liu & Yan Li & Ying Guo & Zhaoran Wang & Ting Wang & Yujing Zhao & Huiru Zhao & Hui Cao & Yu Su & Jiashu Su, 2021.
"A DNA origami-based aptamer nanoarray for potent and reversible anticoagulation in hemodialysis,"
Nature Communications, Nature, vol. 12(1), pages 1-10, December.
Handle:
RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-020-20638-7
DOI: 10.1038/s41467-020-20638-7
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-020-20638-7. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.